SAB Biotherapeutics, Inc. (SABS) Revenue History
SAB Biotherapeutics, Inc. (SABS) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2020-12-31 | $55.24M |
| 2021-12-31 | $60.88M |
| 2022-12-31 | $23.90M |
| 2023-12-31 | $2.24M |
| 2024-12-31 | $1.32M |
| 2025-12-31 | N/A |
How SABS compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| VTGN | Vistagen Therapeutics Inc. | $1.27M |
| DMAC | DiaMedica Therapeutics Inc. | $500.00K |
| MNOV | MediciNova Inc. | $409.66K |
| PLSE | Pulse Biosciences Inc | $350.00K |
| BNTC | Benitec Biopharma Inc. | $75.00K |
These are five companies in the same sector as SABS with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get SAB Biotherapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("SABS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SABS | $3.79 | -3.56% | 0.20M |
| 3 | ||||
| 4 | ||||
| 5 |